Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Alfasigma
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:country |
gptkb:Italy
|
| gptkbp:focusesOn |
oncology
rare diseases metabolic diseases |
| gptkbp:foundedIn |
1957
|
| gptkbp:founder |
gptkb:Claudio_Cavazza
|
| gptkbp:headquartersLocation |
gptkb:Pomezia,_Italy
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Carmustine
gptkb:Dacarbazine L-carnitine |
| gptkbp:numberOfEmployees |
2500
|
| gptkbp:website |
https://www.sigma-tau.it/
|
| gptkbp:bfsParent |
gptkb:Abelcet
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sigma-Tau Pharmaceuticals
|